Meiwu Technology Company Limited (NASDAQ: WNW), a British Virgin Islands company incorporated on December 4, 2018, has announced an agreement with Shenzhen Zhinuo Weichuang Technology Co., Ltd. (“Zhinuo Weichuang”) to enhance its brand influence and market competitiveness. Zhinuo Weichuang, based in Guangdong, China, specializes in research, development, and sales of technology products in smart technology, AI-driven finance, and the internet, as well as providing intelligent services and investment-related activities.
Agreement Details
The agreement, effective from July 1, 2025, to June 30, 2026, includes comprehensive marketing services designed to increase Meiwu’s brand exposure and strengthen its market competitiveness. Zhinuo Weichuang will leverage its digital marketing technologies and channel networks to analyze user data, display data, and browsing behavior across various channels. This approach aims to enable more precise targeting and performance insights for Meiwu’s products, expanding its market reach both domestically and internationally.
Service and Fee Structure
The parties have agreed on a comprehensive service and fee structure, which includes:
- A fixed upfront service fee of RMB 1,000,000
- A monthly services fee of RMB 200,000
The services to be provided by Zhinuo Weichuang include:
- Market research, strategic planning, and account setup
- Ongoing basic operational services covering content planning, account management, and data analysis
- API connections and data interface development
Additionally, a performance-based, tiered fee structure will be implemented, linked to conversion results across major e-commerce platforms such as Taobao, JD.com, Pinduoduo, Douyin, Kuaishou, and WeChat video channel stores.
About Meiwu Technology Company Limited
Meiwu Technology Company Limited has strategically transitioned its business from online sales of selected high-quality food products and short message services to the skincare industry. The company currently engages in the sale of functional skincare products through Xiamen Chunshang Health Technology Co., Ltd. (“Chunshang Xiamen”), an indirect wholly-owned subsidiary in China.
Safe Harbor Statement
Certain statements in this release are “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties, and other factors that could cause actual results to differ materially from those discussed. Important factors include the ability to manage growth, identify and integrate future acquisitions, obtain additional financing, fluctuations in economic and business conditions, and potential changes in the legislative and regulatory environment. The Company undertakes no obligation to update or revise any forward-looking statements except as required by applicable law.
